Clarametyx Biosciences is a biotechnology company that develops immune-enabling biologic therapies.
Clarametyx Biosciences's investors include Rev1 Ventures, 1776 Ventures, CARB-X, Cystic Fibrosis Foundation, JobsOhio.
Clarametyx Biosciences is headquartered in Columbus, United States.
Clarametyx Biosciences is a biotechnology company that develops immune-enabling biologic therapies.
Clarametyx Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Clarametyx Biosciences — Funding & Investors." VCBacked, January 28, 2025, https://www.vcbacked.co/company/clarametyx-biosciences. Accessed July 31, 2026.
VCBacked. (2025). Clarametyx Biosciences — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/clarametyx-biosciences
{{cite web |title=Clarametyx Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/clarametyx-biosciences |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated